Picomole Wins Patent Approval
Picomole Instruments, a Moncton company developing a breath analysis device that detects cancer, yesterday announced that it has received approval from the U.S. Patent and Trademark Office and will patent the device.
Formerly called “LifeSens”, the device is currently unnamed because the company couldn't trademark that name.
Cormier said the patent notice allows the company to protect its proprietary technology as it develops clinical applications. He told Entrevestor that Picomole has completed a small pilot study on lung cancer and, encouraged by the results, is planning a larger